dactinomycin has been researched along with medroxyprogesterone acetate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
| Emrich, D; Luig, H; Nagel, GA; Wander, HE | 1 |
| Boue, A; Gompel, A; Kuttenn, F; Lalardrie, JP; Malet, C; Mauvais-Jarvis, P; Ochoa, C; Prud'homme, JF | 1 |
| Kuramoto, M; Ogawa, M; Yamashita, J | 1 |
| Arici, A; Casey, ML; MacDonald, PC | 1 |
| Tseng, L; Zhu, HH | 1 |
| Chiappetta, C; Hyder, SM; Stancel, GM | 1 |
| Inaba, N; Kawagoe, J; Kurachi, H; Mochizuki, Y; Mori-Abe, A; Ohmichi, M; Oishi, A; Otsu, R; Takahashi, K; Takahashi, T | 1 |
1 trial(s) available for dactinomycin and medroxyprogesterone acetate
| Article | Year |
|---|---|
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
11 other study(ies) available for dactinomycin and medroxyprogesterone acetate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Intensive short-term chemotherapy in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Remission Induction; Vincristine | 1987 |
17 beta-Hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast; Cells, Cultured; Contraceptive Agents, Female; Dactinomycin; Dose-Response Relationship, Drug; Epithelium; Estradiol; Female; Fibroblasts; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate | 1984 |
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured | 1995 |
Progestin regulation of interleukin-8 mRNA levels and protein synthesis in human endometrial stromal cells.
Topics: Base Sequence; Cells, Cultured; Dactinomycin; Endometrium; Female; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-8; Medroxyprogesterone Acetate; Molecular Sequence Data; Progesterone; Progesterone Congeners; Progestins; Protein Synthesis Inhibitors; Recombinant Proteins; RNA, Messenger; Stromal Cells; Transcription, Genetic | 1996 |
Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
Topics: Cycloheximide; Dactinomycin; Endometrium; Estradiol; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Immunohistochemistry; Kinetics; Medroxyprogesterone Acetate; Mifepristone; Progesterone; Progestins; Protein Synthesis Inhibitors; Receptors, Progesterone; RNA, Messenger; Stromal Cells | 1997 |
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Topics: Alternative Splicing; Antimetabolites, Antineoplastic; Blotting, Northern; Breast Neoplasms; Culture Media; Dactinomycin; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Estrogens; Glucocorticoids; Hormone Antagonists; Humans; Lymphokines; Medroxyprogesterone Acetate; Mifepristone; Progesterone; Progestins; Protein Isoforms; Protein Synthesis Inhibitors; Puromycin; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells.
Topics: Animals; Cells, Cultured; Chlorocebus aethiops; Contraceptive Agents, Female; COS Cells; Dactinomycin; Endothelial Cells; Endothelium, Vascular; Estradiol; Female; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Progesterone; Umbilical Veins | 2004 |